HJCC公司发布了其新一代转基因小鼠平台AlivaMab Mouse-NGX，用于发现人类抗体药物
Release time:2025-12-16
该抗体能有效对抗RSV的A和B亚型，并揭示了其独特的作用表位，为开发下一代RSV疗法和..
Related news
-
HJCC has released its next-generation genetically modified mouse platform, AlivaMab Mouse NGX, for the discovery of human antibody drugs2025.12.16Learn More
-
HJCC has released its next-generation genetically modified mouse platform, AlivaMab Mouse NGX, for the discovery of human antibody drugs2025.12.16
Learn More